New York, states reach $700 million settlement with Reckitt over opioid probes

(Reuters) - New York and five other states have reached a $700 million (£543.27 million) settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday. Reckitt in July agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out carried out an illegal scheme to boost sales of an opioid addiction..